AAO report highlights Retinomax for amblyopia screening in children

A major report from the American Academy of Ophthalmology (AAO) highlights the value of instrument-based screening in the early detection of amblyopia and amblyopia risk factors in children.

Among the technologies evaluated, Retinomax is one of the most widely studied handheld autorefractors used in clinical practice.

Why do eye care professionals choose Retinomax?

- Strong screening sensitivity: Across multiple studies, Retinomax has demonstrated sensitivity ranging from approximately 70% to 95% in detecting amblyopia risk factors—supporting early identification of conditions such as astigmatism and hyperopia.

- Controlled, eye-by-eye measurement: Its targeted monocular assessment enables reliable refractive data (sphere and cylinder) in screening environments.

- Built-in quality control: With an integrated confidence indicator, practitioners can assess measurement quality in real time—supporting consistent screening outcomes, even in schools and outreach settings.

Retinomax supports reliable, accessible vision screening, helping more children receive timely care when it matters most.
Full report available at: https://lnkd.in/e-MmQEaV

ℹ️ More about the Retinomax series on https://lnkd.in/eJprFtgk
📧 Sales enquiry's email: sales@bibonline.co.uk